Apoptotic cell death induced by 5-aminolaevulinic acid-mediated photodynamic therapy of hypertrophic scar-derived fibroblasts

Journal of Dermatological Treatment

Volumn 25, Issue 5, 2014, Pages 428-433

  Li, Xin ^a   Zhou, Zhao Pin ^b   Hu, Li ^a   Zhang, Wen Jie ^a   Li, Wei ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

5 aminolevulinic acid; Apoptosis; Hypertrophic scar; Photodynamic therapy

Indexed keywords

AMINOLEVULINIC ACID; CHOLECYSTOKININ OCTAPEPTIDE; DNA NUCLEOTIDYLEXOTRANSFERASE; LIPOCORTIN 5; PROTOPORPHYRIN;

APOPTOSIS; ARTICLE; CELL SURVIVAL; CELL TYPE; CLINICAL ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DENSITY; DRUG EFFECT; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HYPERTROPHIC SCAR; LASER; NICK END LABELING; PHOTODYNAMIC THERAPY; PHOTOTOXICITY; PRIORITY JOURNAL; SKIN FIBROBLAST;

ADOLESCENT; ADULT; AMINOLEVULINIC ACID; APOPTOSIS; CELLS, CULTURED; CHILD; CICATRIX, HYPERTROPHIC; FIBROBLASTS; HUMANS; MIDDLE AGED; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; SKIN DISEASES; YOUNG ADULT;

EID: 84890323761     PISSN: 09546634     EISSN: 14711753     Source Type: Journal    
DOI: 10.3109/09546634.2012.697987     Document Type: Article

References (30)

1. Sephel GC, Woodward SC. Repair, regeneration, and fibrosis. In Rubin E, editor. Rubin's Pathology. Baltimore: Lippincott, Williams & Wilkins, 2001. p 84-117
2. Slemp AE, Kirschner RE. Keloids and scars: A review of keloids and scars, their pathogenesis, risk factors, and management. Curr Opin Pediatr. 2006;18:396-402
3. Gauglitz GG, Korting HC, Pavicic T, Ruzicka T, Jeschke MG. Hypertrophic scarring and keloids: Pathomechanisms and current and emerging treatment strategies. Mol Med. 2011;17:113-125
4. Clark JA, Leung KS, Cheng JC, Leung PC. The hypertrophic scar and microcirculation properties. Burns. 1996;22:447-450
5. Amadeu T, Braune A, Mandarim-de-Lacerda C, Porto LC, Desmoulière A, Costa A. Vascularization pattern in hypertrophic scars and keloids: A stereological analysis. Pathol Res Pract. 2003;199:469-473
6. Wang XQ, Liu YK, Qing C, Lu SL. A review of the effectiveness of antimitotic drug injections for hypertrophic scars and keloids. Ann Plast Surg. 2009;63:688-692
7. Vrijman C, van Drooge AM, Limpens J, Bos JD, van der Veen JP, Spuls PI, et al. Laser and intense pulsed light therapy for the treatment of hypertrophic scars: A systematic review. Br J Dermatol. 2011;165: 934-942
8. Fayter D, Corbett M, Heirs M, Fox D, Eastwood A. A systematic review of photodynamic therapy in the treatment of pre-cancerous skin conditions, Barrett's oesophagus and cancers of the biliary tract, brain, head and neck, lung, oesophagus and skin. Health Technol Assess. 2010;14:1-288
9. Babilas P, Schreml S, Landthaler M, Szeimies RM. Photodynamic therapy in dermatology: State-of-the-art. Photodermatol Photoimmunol Photomed. 2010;26:118-132
10. Oleinick NL, Morris RL, Belichenko I. The role of apoptosis in response to photodynamic therapy: What, where, why, and how. Photochem Photobiol Sci. 2002;1:1-21
11. Dougherty TJ, Gomer CJ, Henderson BW, Jori G, Kessel D, Korbelik M, et al. Photodynamic therapy. J Natl Cancer Inst. 1998; 90:889-905
12. Chen B, Pogue BW, Hoopes PJ, Hasan T. Vascular and cellular targeting for photodynamic therapy. Crit Rev Eukaryot Gene Expr. 2006;16:279-305
13. Cai H, Gu Y, Sun Q, Zeng J, Dong N, Zhao G. Effect of hematoporphyrin monomethyl ether-mediated photodynamic therapy on hypertrophic scar fibroblasts. Photodermatol Photoimmunol Photomed. 2011;27:90-96
14. Chiu LL, Sun CH, Yeh AT, Torkian B, Karamzadeh A, Tromberg B, et al. Photodynamic therapy on keloid fibroblasts in tissue-engineered keratinocyte-fibroblastco-culture. Lasers Surg Med. 2005;37:231-244
15. Nie Z, Bayat A, Behzad F, Rhodes LE. Positive response of a recurrent keloid scar to topical methyl aminolevulinatephotodynamic therapy. Photodermatol Photoimmunol Photomed. 2010;26:330-332
16. Campbell SM, Tyrrell J, Marshall R, Curnow A. Effect of MALphotodynamic therapy on hypertrophic scarring. Photodiagnosis Photodyn Ther. 2010;7:183-188
17. Bruscino N, Lotti T, Rossi R. Photodynamic therapy for a hypertrophic scarring: A promising choice. Photodermatol Photoimmunol Photomed. 2011;27:334-335
18. Peng Q, Berg K, Moan J, Kongshaug M, Nesland JM. 5-Aminolevulinic acid-based photodynamic therapy: Principles and experimental research. Photochem Photobiol. 1997;65:235-251
19. Blume JE, Oseroff AR. Aminolevulinic acid photodynamic therapy for skin cancers. Dermatol Clin. 2007;25:5-14
20. Lehmann P. Methyl aminolaevulinate-photodynamic therapy: A review of clinical trials in the treatment of actinic keratoses and nonmelanoma skin cancer. Br J Dermatol. 2007;156:793-801
21. Chen FG, Zhang WJ, Bi D, Liu W, Wei X, Chen FF, et al. Clonal analysis of nestin(-) vimentin(+) multipotent fibroblasts isolated from human dermis. J Cell Sci. 2007;120:2875-2883
22. Wu SM, Ren QG, Zhou MO, Peng Q, Chen JY. Protoporphyrin IX production and its photodynamic effects on glioma cells, neuroblastoma cells and normal cerebellar granule cells in vitro with 5-aminolevulinic acid and its hexylester. Cancer Lett. 2003;200:123-131
23. Li W, Zhang WJ, Ohnishi K, Yamada I, Ohno R, Hashimoto K. 5-Aminolaevulinic acid-mediated photodynamic therapy in multidrug resistant leukemia cells. J Photochem Photobiol B. 2001;60:79-86
24. Berman B, Perez OA, Konda S, Kohut BE, Viera MH, Delgado S, et al. A review of the biologic effects, clinical efficacy, and safety of silicone elastomer sheeting for hypertrophic and keloid scar treatment and management. Dermatol Surg. 2007;33:1291-1302
25. Niessen FB, Spauwen PH, Schalkwijk J, Kon M. On the nature of hypertrophic scars and keloids: A review. Plast Reconstr Surg. 1999;104: 1435-1458
26. Buytaert E, Dewaele M, Agostinis P. Molecular effectors of multiple cell death pathways initiated by photodynamic therapy. Biochim Biophys Acta. 2007;1776:86-107
27. Kessel D, Vicente MG, Reiners JJ Jr. Initiation of apoptosis and autophagy by photodynamic therapy. Lasers Surg Med. 2006;38: 482-488
28. Tsai JC, Wu CL, Chien HF, Chen CT. Reorganization of cytoskeleton induced by 5-aminolevulinic acid-mediated photodynamic therapy and its correlation with mitochondrial dysfunction. Lasers Surg Med. 2005;36:398-408
29. Noodt BB, Berg K, Stokke T, Peng Q, Nesland JM. Apoptosis and necrosis induced with light and 5-aminolaevulinic acid-derived protoporphyrin IX. Br J Cancer. 1996;74:22-29
30. Li W, Yamada I, Masumoto K, Ueda Y, Hashimoto K. Photodynamic therapy with intradermal administration of 5-aminolevulinic acid for port-wine stains. J Dermatolog Treat. 2010;21: 232-239